Navigation Links
Nicotine Replacement Therapy Is Safe, Effective and Can Help Reverse Mental Acuity Deficits in Smokers Who Are Quitting, Including Commercial and Private Pilots
Date:5/22/2008

Commit 4 mg Lozenge helps reverse symptoms associated with nicotine withdrawal including difficulty concentrating, attention deficit, memory

deficit and selective attention deficit

PITTSBURGH, May 22 /PRNewswire-FirstCall/ -- In light of today's announcement by the Federal Aviation Administration (FAA) that it has removed a prescription anti-smoking pill from their approved list of safe medications for pilots and air-traffic controllers, it's important to note this news does not include nicotine replacement therapy (NRT) which is deemed safe and effective. (1) Further, recent research has found the Commit 4 mg lozenge has been clinically proven to help reverse nicotine withdrawal symptoms associated with quitting smoking including the following: difficulty concentrating, attention deficit, short-term memory deficit and selective attention deficit (2) -- some of the issues at the core of today's report.

In 1994, the FAA requested the Centers for Disease Control (CDC) assemble an expert panel to examine the effects of smoking and tobacco addiction and withdrawal on pilot performance and airline safety. As part of the panel's conclusion, they found NRT to be safe, effective treatment option for pilots who smoke. (1) Those recommendations stand to this day.

"Nicotine withdrawal is a serious issue for pilots who are in the process of quitting smoking, and today's news could have a dramatic impact on these individuals," said Jack E. Henningfield, Ph.D., Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, Vice President Research & Health Policy, Pinney Associates, and consultant for GlaxoSmithKline Consumer Healthcare. "What they need to understand is that NRT such as the Commit lozenge is safe for quitters, including pilots who use it while flying, (1) and can help with the serious effects of withdrawal."

Smoking remains one of the leading causes of p
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
2. DNA (driver of nicotine addiction)
3. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
4. Smokers Brain Centers Activate During Nicotine Cravings
5. Study suggests nicotine addiction might be controlled by influencing brain mechanisms
6. Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show
7. Studies of 20,000 smokers show quit rates double with counseling and free nicotine patches
8. Nicotine-Reduced Cigarettes Could Boost Quitting
9. Nicotine addiction slashed in test of new cigarette smoking strategy
10. Nicotine Plus Alcohol May Be Tough to Beat
11. Genes, brain chemistry may dictate nicotine cravings, says CU-Boulder study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... 03, 2015 Leading international program provider, ... will be awarding the 2015 Harris Wofford Global Service ... Ghebrendrias, are the deserving recipients of the award named ... Harris Llewellyn Wofford. The two recipients were chosen for ... global health. , CFHI is one of seven ...
(Date:5/3/2015)... Missouri (PRWEB) May 03, 2015 ... business that will directly impact your career? The ... designed for dynamic leaders in multinational companies and ... company. In a changing global landscape, differences in ... and relationships. The EMIB program develops the global ...
(Date:5/3/2015)... May 03, 2015 HealthPostures, a ... solutions, announces its appearance at the , May 5 ... that HealthPostures will exhibit at the conference include its ... sit stand solutions is the 6100 TaskMate Executive. Features ... control, an adjustable keyboard tray, extended platform work surface ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 β€œ ActOn ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... to get connected with organizations to make a difference. , ... are very few things that aren’t about money, which is ...
(Date:5/2/2015)... May 02, 2015 β€œ Peachtree Audio ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... audio equipment. , Music is an important part ... be pampered and given the royal treatment. Peachtree Audio ...
Breaking Medicine News(10 mins):Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2
... vice minister of health in China has sought for more ... organs by patients in their country//. According to him there ... and the actual donations. ,Statistics reveal that 1.5 ... are lucky enough to find organs. In China organs are ...
... come out in support of old wisdom, in order ... health challenges// of today. ,Improving pupil-teacher ... very ethos(institutional culture) of a school will do the ... superiority of aged principles to newer ones such ...
... research conducted by Dr Michael Kisley, a psychologist from the ... more positive// outlook towards life than young people. These findings ... than one hundred and fifty participants took part in this ... neutral and negative aspects of life. The viewing was restricted ...
... on antiretroviral therapy (ART) experience liver enzyme elevation ... advised when prescribing ART in this population. Results ... Antiretrovirals) study indicate that coinfection itself may be ... ,The study investigated whether coinfected individuals on ...
... of AZT, lamivudine, and nevirapine (AZT/3TC/NVP) taken from week ... delivery resulted in significantly reduced HIV levels in breast ... the breast milk of women who were not treated ... Enhancement Against AIDS and Malnutrition) in Mozambique conducted this ...
... The use of medicines to fight cardiovascular disease has been ... past several decades,// as combinations of interventions and medicinal therapy ... ,Two studies has looked at the measurable impact of ... demonstrates that lower doses of therapies may prove to be ...
Cached Medicine News:Health News:'School Sermons' Need a Comeback 2Health News:Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 4Health News:Low-dose Aspirin Beats High-dose After Cardiac Surgery 2Health News:Low-dose Aspirin Beats High-dose After Cardiac Surgery 3
(Date:5/1/2015)... -- Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) ... results of the Phase 3 Rocket 1 trail of ... to meet its end points, compelling data from the ... studies. An analyst report on AERI that ... analyst summary, valuation, and recommendation can be viewed by ...
(Date:4/30/2015)... Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its first quarter ended March 31, ... quarter of 2015 was $116.2 million, up $14.5 million ... down $5.3 million or 4.4% from the fourth quarter ... as reported in accordance with U.S. generally accepted accounting ...
(Date:4/30/2015)... 30, 2015  Tandem Diabetes Care ® , Inc. (NASDAQ: ... the t:slim ® and t:flex™ Insulin Pumps, today reported ... In comparing the first quarter of 2015 ... 53 percent to $12.3 million from $8.1 million , ... 1,723 pumps "Our investment in resources to build ...
Breaking Medicine Technology:All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6
... A new study published online today ... NEJM) shows bevacizumab (Avastin) is as effective as ranibizumab ... treating age-related macular degeneration (AMD). The ... Trials" (CATT) study, a pioneering comparative effectiveness trial made ...
... 2011 PharmaNet Development Group, Inc., a leading provider ... and medical device companies, announced today that Valerie Palumbo ... Quality Assurance. "We are very pleased ... President, PharmaNet Development Group. "Valerie brings deep experience in ...
Cached Medicine Technology:Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 2Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 3Cleveland Clinic-Led Study Finds Bevacizumab as Effective as FDA-Approved Ranibizumab in Treating Macular Degeneration 4
Titanium. Curved shafts with 5.5 mm tying platform. Round knurled handle with dull finish. Overall length 4.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Stra...
Angled 45 degree shafts with tying platform. Wide serrated handle with dull finish. Overall length 4.2 inches....
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Curved shafts. Overall length 3.9 inches....
Medicine Products: